Table 1.
Characteristics at time of baseline CMR
| NIDCM N = 12 | Normal N = 11 | P | |
|---|---|---|---|
| Age (years) | 52 (45, 55) | 55 (52, 58) | 0.039 |
| Male | 8 (67%) | 3 (27%) | 0.10 |
| Medications | |||
| Beta blocker | 12 (100%) | 0 (0%) | |
| ACE‐I or ARB | 12 (100%) | 0 (0%) | |
| Diuretic | 7 (58%) | 0 (0%) | |
| BMI (kg/m2) | 30.0 (25.7, 34.3) | 24.7 (21.0, 27.8) | 0.023 |
| BSA (m2) | 2.07 (1.85, 2.33) | 1.63 (1.56, 2.01) | 0.019 |
| NYHA class | |||
| 1 | 0 (0%) | 7 (100%) | |
| 2 | 5 (42%) | 0 (0%) | |
| 3 | 7 (58%) | 0 (0%) | |
| Heart rate (bpm) | 67 (58, 71) | 62 (57, 68) | 0.48 |
| Systolic BP (mmHg) | 121 (115, 125) | 120 (113, 125) | 0.62 |
| Diastolic BP (mmHg) | 67 (63, 73) | 72 (67, 82) | 0.25 |
| MAP (mmHg) | 84 (80, 90) | 87 (82, 95) | 0.39 |
Median (interquartile range). ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocking drug; BMI, body mass index; BP, blood pressure; bpm, beats per minute; BSA, body surface area; CMR, cardiac magnetic resonance imaging; MAP, mean arterial pressure; mmHg, millimetres Mercury; NIDCM, nonischemic dilated cardiomyopathy; NYHA, New York Heart Association.